On April 15 2020, the Board of Directors of Soleno Therapeutics, Inc. accepted Stuart Collinson’s resignation from the Board, including his resignation from the Board’s audit committee, effective April 15, 2020. The resignation of Mr. Collinson was not the result of any disagreement with the Company relating to the Company’s operations, policies or practices. On April 17, 2020, the Board, upon recommendation from the Board’s nominating committee, appointed Birgitte Volck as a member of the Board’s audit committee, effective immediately. Following this appointment, the Board’s audit committee consists of Andrew Sinclair, Birgitte Volck and William G. Harris (chairperson).